Vanguard Group Inc Emergent Bio Solutions Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,411,549 shares of EBS stock, worth $23.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,411,549
Previous 2,974,638
14.69%
Holding current value
$23.5 Million
Previous $7.14 Million
20.9%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding EBS
# of Institutions
134Shares Held
35.6MCall Options Held
78.7KPut Options Held
75.1K-
Black Rock Inc. New York, NY7.06MShares$48.6 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA4.15MShares$28.6 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.91MShares$13.1 Million0.19% of portfolio
-
Morgan Stanley New York, NY1.29MShares$8.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.12MShares$7.73 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $344M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...